Brief: Bluebird Bio Q3 EPS USD -0.31
14/11/2024 12:00
Nov 14 (Reuters) - Bluebird Bio Q3 operating income USD -66.919 million. * Q3 net income USD -60.808 million * Q3 basic EPS USD -0.31 * Q3 operating expenses USD 65.75 million * Q3 pretax profit USD -60.866 million
Recent news on bluebird bio
See all newsBrief: Bluebird Bio Announces Completion Of Acquisition By Carlyle And SK Capital
Brief: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
Brief: Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment